Adjuvant PD-1 antibody in recurrent, previously irradiated oral cavity cancer treated with salvage surgery
Shengjin Dou(Shanghai Jiao Tong University), Guopei Zhu(Fudan University Shanghai Cancer Center), Lulu Ye(Shanghai Jiao Tong University), Lai‐ping Zhong(Huashan Hospital), Shuyang Sun(Guangxi Medical University), Jingjing Sun(Shanghai Jiao Tong University), Rongrong Li(Qilu Hospital of Shandong University), Jiang Li(Chengdu University of Technology), Wen Jiang(Shanghai Jiao Tong University), Yanli Yao(Shanghai Ninth People's Hospital), Lin Zhang(The University of Melbourne), Sicheng Wu(China-Japan Friendship Hospital)
Cited by 2
Related Papers
Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma
|Oncotarget|2014|339
Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study
|Cancers|2022|303
Updated epidemiology of gastrointestinal cancers in East Asia
|Nature Reviews Gastroenterology & Hepatology|2023|258
High salt primes a specific activation state of macrophages, M(Na)
|Cell Research|2015|243
Nanomaterials for Cancer Precision Medicine
|Advanced Materials|2018|212